Innovia

8 articles about Innovia

• 

  GSK Sells Innoviva Shares Back to Respiratory Partner for $392 Million

  5/21/2021

  GSK said the sale of Innovia stock would help GSK invest in other “strategic priorities,” likely those aimed at plans to separate into two main offerings over the next couple of years.
• 

  AstraZeneca COPD Drug Fails to Distinguish Itself from Rival GSK Treatment

  8/23/2018

  AstraZeneca has seen another setback in a late-stage trial for chronic obstructive pulmonary disease (COPD) treatments. The latest stumbling block includes a failure for AstraZeneca’s investigational treatment to distinguish itself from a drug already marketed by rival GlaxoSmithKline.

• Theravance Biopharma Highlights GlaxoSmithKline And Innovia's Receipt Of Positive Opinion From CHMP In Europe For Trelegy Ellipta (Closed Triple)

  9/18/2017

• Proxy War Between Bay Area Innovia and Sarissa Heats Up, Could Mother of All Bombs Follow at Next Week’s Board Meeting?

  4/14/2017

• Innovia To Report Fourth Quarter And Full Year 2016 Financial Results On February 9, 2017 At 5:00 P.M. EST

  2/3/2017

• Theravance Biopharma Highlights Acceleration Of Timeline For Filing U.S. New Drug Application For The Closed Triple By GlaxoSmithKline And Innovia

  6/3/2016

• Innovia Enters the Single Incision Laparoscopy Market With the InnoPort(TM)

  1/25/2011

• Innovia Receives FDA Clearance For The InnoPort(TM)

  6/2/2009